ePulmonology Review Series Renewed for a Second Volume

MANHATTAN, N.Y. - March 25, 2022 - PRLog -- DKBmed, LLC, in collaboration with the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing, is releasing a second volume of its popular ePulmonology Review series. This new installment, consisting of three journal briefs and three case-based podcasts, will assist pulmonologists and other clinicians in their efforts to optimize management of asthma and chronic obstructive pulmonary disease (COPD).

The program can be found at epulmonologyreview.org (https://elit.dkbmed.com/programs/7/volumes/20)

The sudden emergence of SARS-CoV-2 has complicated the care of patients with asthma and COPD. Although patients with these conditions are not more susceptible to infection with SARS-CoV-2, evidence from a meta-analysis of respiratory studies indicates that they have a higher risk of severe disease and mortality. Further complicating matters, medications used to manage asthma and other respiratory conditions can compound the likelihood of opportunistic infections. Even with treatment, patients with moderate to severe asthma and COPD can struggle to control exacerbations. The therapeutic landscape has expanded in recent years to address existing treatment gaps, but some of the new biologic medications require careful patient assessment before selecting the best option for each patient. Clinicians treating patients with respiratory conditions like asthma and COPD must weigh efficacy with safety during an ongoing pandemic.

"As a respiratory disease, COVID-19 intuitively and severely complicates the work we do as pulmonologists," notes Lesley Simon, Medical Director at DKBmed. "GOLD Guidelines recognize patients with COPD as among the most severely affected by COVID-19. With that in mind, we need to carefully weigh the pros and cons of treatments for our patients, which are growing more plentiful each passing year. In the midst of a pandemic, up-to-date educational initiatives would be invaluable and can help ensure that we are making the best treatment decisions possible for our patients."

Volume 2 of the ePulmonology Review will examine critical topics relevant to the care of patients with asthma, COPD, and COVID-19, including:

• Navigating updated clinical guidelines, differences between guidelines, and their implications on how clinicians select therapies
• Incorporating new treatments into clinical practice for patients with asthma and/or COPD
• Managing treatment-related adverse events in patients, as well as monitoring treatment efficacy

ePulmonology Review is one component of the highly successful and popular eLiterature Review series published through DKBmed's collaboration with the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing. Each installment consists of a newsletter and podcast. To view this and similar learning programs centered on other conditions, including cystic fibrosis, HIV, and COPD, visit elit.dkbmed.com (https://elit.dkbmed.com/programs/1).

​